These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 18855853)
21. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial. Miehlke S; Madisch A; Bethke B; Morgner A; Kuhlisch E; Henker C; Vogel G; Andersen M; Meier E; Baretton G; Stolte M Gastroenterology; 2008 Nov; 135(5):1510-6. PubMed ID: 18926826 [TBL] [Abstract][Full Text] [Related]
22. Oral 5-ASA therapy in ulcerative colitis: what are the implications of the new formulations? Sandborn WJ J Clin Gastroenterol; 2008 Apr; 42(4):338-44. PubMed ID: 18277908 [TBL] [Abstract][Full Text] [Related]
23. Treatment of severe ulcerative colitis: differences in elderly patients? Vavricka SR; Rogler G Dig Dis; 2009; 27(3):315-21. PubMed ID: 19786758 [TBL] [Abstract][Full Text] [Related]
24. Mesalamine with MMX technology for the treatment of ulcerative colitis. Schreiber S; Kamm MA; Lichtenstein GR Expert Rev Gastroenterol Hepatol; 2008 Jun; 2(3):299-314. PubMed ID: 19072380 [TBL] [Abstract][Full Text] [Related]
25. Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study. Scherl EJ; Pruitt R; Gordon GL; Lamet M; Shaw A; Huang S; Mareya S; Forbes WP Am J Gastroenterol; 2009 Jun; 104(6):1452-9. PubMed ID: 19491859 [TBL] [Abstract][Full Text] [Related]
26. Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis. Maser EA; Deconda D; Lichtiger S; Ullman T; Present DH; Kornbluth A Clin Gastroenterol Hepatol; 2008 Oct; 6(10):1112-6. PubMed ID: 18928936 [TBL] [Abstract][Full Text] [Related]
27. Management of acute severe ulcerative colitis. Doherty GA; Cheifetz AS Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):395-405. PubMed ID: 19673626 [TBL] [Abstract][Full Text] [Related]
29. Delayed-release oral mesalamine 4.8 g/day (800-mg tablet) is effective for patients with moderately active ulcerative colitis. Sandborn WJ; Regula J; Feagan BG; Belousova E; Jojic N; Lukas M; Yacyshyn B; Krzeski P; Yeh CH; Messer CA; Hanauer SB Gastroenterology; 2009 Dec; 137(6):1934-43.e1-3. PubMed ID: 19766640 [TBL] [Abstract][Full Text] [Related]
30. Experience of maintenance infliximab therapy for refractory ulcerative colitis from six centres in England. Russo EA; Harris AW; Campbell S; Lindsay J; Hart A; Arebi N; Milestone A; Tsai HH; Walters J; Carpani M; Westaby D; Thillainayagam A; Bansi D; Ghosh S Aliment Pharmacol Ther; 2009 Feb; 29(3):308-14. PubMed ID: 19035973 [TBL] [Abstract][Full Text] [Related]
31. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy. Plontke SK; Löwenheim H; Mertens J; Engel C; Meisner C; Weidner A; Zimmermann R; Preyer S; Koitschev A; Zenner HP Laryngoscope; 2009 Feb; 119(2):359-69. PubMed ID: 19172627 [TBL] [Abstract][Full Text] [Related]
32. Guillain-Barre in a patient with ankylosing spondylitis secondary to ulcerative colitis on infliximab therapy. Bouchra A; Benbouazza K; Hajjaj-Hassouni N Clin Rheumatol; 2009 Jun; 28 Suppl 1():S53-5. PubMed ID: 19277812 [TBL] [Abstract][Full Text] [Related]
34. A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy. Woodle ES; First MR; Pirsch J; Shihab F; Gaber AO; Van Veldhuisen P; Ann Surg; 2008 Oct; 248(4):564-77. PubMed ID: 18936569 [TBL] [Abstract][Full Text] [Related]
35. Encapsulated mesalamine granules (Apriso) for ulcerative colitis. Med Lett Drugs Ther; 2009 May; 51(1312):38-9. PubMed ID: 19448588 [TBL] [Abstract][Full Text] [Related]
36. A pilot study of leukocytapheresis efficacy with 1.5 liter blood processing volume in patients with ulcerative colitis. Shimada M; Iwase H; Tsuzuki T; Hirashima N; Kobayashi K; Hibino Y; Watanabe H; Ryuge N; Ando T; Goto H; Yagi Y; Tsujikawa T; Andoh A Ther Apher Dial; 2008 Oct; 12(5):368-73. PubMed ID: 18937719 [TBL] [Abstract][Full Text] [Related]
37. Serial changes of cytokines in active ulcerative colitis: effects of antibiotic combination therapy. Sato K; Chiba T; Ohkusa T Hepatogastroenterology; 2009; 56(93):1016-21. PubMed ID: 19760932 [TBL] [Abstract][Full Text] [Related]
38. Balsalazide disodium for the treatment of ulcerative colitis. Patil SA; Moss AC Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):177-84. PubMed ID: 19072352 [TBL] [Abstract][Full Text] [Related]
39. Two cases of cutaneous chronic graft versus host disease in treatment with psoralen plus ultraviolet-A-bath photochemotherapy. Hoffner MV; Carrizosa Esquivel A; Pulpillo Ruiz A; Herrera Saval A; Conejo-Mir J; Camacho FM J Drugs Dermatol; 2009 Nov; 8(11):1027-9. PubMed ID: 19894371 [TBL] [Abstract][Full Text] [Related]
40. Ulcerative colitis: current medical therapy and strategies for improving medication adherence. Zhang Z; Kennedy H Eur J Gastroenterol Hepatol; 2009 Jan; 21(1):1-8. PubMed ID: 19011573 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]